Conditions: Pain
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 36
Healthy volunteers: yes

Brief summary:
This study will establish the bioequivalence of the 20%, milled, roller compaction final market image (FMI) etoricoxib tablets and 30% unmilled, roller compaction (UMC) etoricoxib tablets.

Detailed description:

Arms:
arm 1: Etoricoxib, 20% tablet arm 2: Etoricoxib, 30% tablet

Interventions: intervention 1: etoricoxib intervention 2: Comparator: etoricoxib
Intervention descriptions: intervention 1: Single dose etoricoxib 120 mg 20% final market image tablet in one of two treatment periods. intervention 2: Single dose etoricoxib 120 mg 30% unmilled, roller compaction tablet in one of two treatment periods.

Protocol document: